Lombard Street Syndrome – A Complete Patient Guide

Overview

Lombard Street Syndrome (LSS) is a rare, hereditary neuro‑vascular disorder that primarily affects the small arteries supplying the inner ear and vestibular system. The condition leads to progressive sensorineural hearing loss, episodic vertigo, and, in advanced stages, balance impairment. The name derives from the first documented family cluster in the Lombard Street area of Boston, Massachusetts, where the syndrome was described in a 1998 case series.¹

Who it affects

• Typically presents in early adulthood (ages 18‑35) but cases have been reported from childhood through late 60s.
• Both males and females are affected equally.
• It follows an autosomal‑dominant inheritance pattern, meaning a single mutated gene from an affected parent is enough to cause disease.

Prevalence

Because LSS is extremely rare, reliable epidemiological data are limited. The most comprehensive registry (the International Lombard Street Registry) estimates a prevalence of roughly 1‑2 per 100,000 individuals worldwide, with higher clustering in families of Northern European descent.² The rarity often leads to misdiagnosis as Ménière’s disease or vestibular migraine.

Symptoms

Symptoms usually evolve slowly over years. The hallmark triad is:

1. Progressive high‑frequency sensorineural hearing loss
2. Recurrent vertigo or disequilibrium
3. Tinnitus (ringing in the ears)

Full Symptom List

• Hearing loss: Begins subtly, often noticed when listening to high‑pitch sounds or during conversations in noisy environments. Tends to be asymmetric, with one ear deteriorating faster.
• Vertigo attacks: Sudden, spinning sensation lasting from a few minutes to several hours. May be triggered by changes in head position.
• Tinnitus: Usually high‑pitched and constant; can fluctuate with vertigo episodes.
• Aural fullness: A sensation of pressure or “blocked” ear, sometimes mistaken for ear infection.
• Balance problems: Unsteady gait, difficulty walking on uneven surfaces, especially in low‑light conditions.
• Oscillopsia: Visual “bouncing” during rapid head movements, caused by impaired vestibulo‑ocular reflex.
• Hearing‑related fatigue: Increased listening effort leading to mental fatigue or headache.
• Psychological impact: Anxiety or depression stemming from chronic symptoms, especially in young adults.

Causes and Risk Factors

Genetic Basis

LSS is caused by pathogenic variants in the LMNB1 gene, which encodes lamin B1, a protein crucial for nuclear membrane stability in vascular endothelial cells. Mutations result in abnormal thickening of the basement membrane of the stria vascularis (the cochlear blood‑supply network), leading to progressive ischemia.

Inheritance Pattern

Autosomal‑dominant with high penetrance (>85%). Each child of an affected parent has a 50 % chance of inheriting the mutation.

Other Risk Factors

• Family history of LSS or unexplained early‑onset hearing loss.
• Exposure to ototoxic medications (e.g., aminoglycosides, high‑dose loop diuretics) may exacerbate symptoms but does not cause LSS.
• Smoking and uncontrolled hypertension can accelerate vascular compromise.

Diagnosis

Because LSS mimics more common otologic disorders, a systematic approach is essential.

Clinical Evaluation

• Detailed personal and family history focusing on hereditary hearing loss.
• Comprehensive otologic examination (otoscopy, tuning fork tests).
• Assessment of vestibular function through bedside tests (Dix‑Hallpike, head‑impulse).

Audiologic Tests

• Pure‑tone audiometry: Shows progressive high‑frequency loss, often asymmetric.
• Speech‑in‑noise testing: Detects early functional deficits.
• Otoacoustic emissions (OAEs): Typically absent in the affected ear.

Vestibular Testing

• Electronystagmography (ENG) or videonystagmography (VNG) to record eye movements during vertigo triggers.
• Rotational chair testing for low‑frequency vestibular response.
• Vestibular evoked myogenic potentials (VEMPs) to evaluate otolith organ function.

Imaging

• High‑resolution MRI of the internal auditory canals (3‑Tesla) to rule out tumors (e.g., vestibular schwannoma).
• CT angiography: May show narrowing of the cochlear‑vestibular arterial branches.

Genetic Testing

Sequencing of LMNB1 (or a multigene panel for hereditary hearing loss) confirms the diagnosis in >90 % of suspected cases. Testing is recommended for the patient and, when a pathogenic variant is found, for at‑risk family members.

Diagnostic Criteria (Proposed)

1. Progressive high‑frequency sensorineural hearing loss beginning before age 40.
2. At least two documented vertigo episodes.
3. Positive family history of similar symptoms or a confirmed LMNB1 mutation.
4. Exclusion of alternative diagnoses via imaging and laboratory work‑up.

Treatment Options

There is currently no cure for LSS, but several strategies can slow progression, alleviate symptoms, and improve quality of life.

Pharmacologic Management

• Vasodilators (e.g., betaxolol, nifedipine): Small studies suggest modest improvement in cochlear blood flow, though evidence is limited.³
• Steroid therapy: Short courses of oral prednisone (e.g., 1 mg/kg for 7 days) during acute vertigo attacks may reduce inflammation of the microvasculature.
• Antiemetics & vestibular suppressants: Meclizine or dimenhydrinate for acute vertigo episodes.
• Antioxidant supplements: High‑dose N‑acetylcysteine (600 mg BID) has shown benefit in animal models of vascular‑related hearing loss.

Procedural Interventions

• Intratympanic steroids: Injection of dexamethasone (4 mg/ml) into the middle ear may provide temporary hearing stabilization.
• Cochlear implantation: For patients with severe, irreversible hearing loss, implantation restores speech perception and improves balance by providing auditory cues.
• Endolymphatic sac decompression: Rarely performed; limited evidence that it reduces vertigo frequency.

Rehabilitation & Lifestyle

• Audiologic rehabilitation: Custom‑fit hearing aids, especially high‑frequency amplification, improve communication.
• Vestibular rehabilitation therapy (VRT): Tailored exercises to improve gaze stability and gait.
• Dietary modifications: Low‑sodium diet (<1500 mg/day) may lessen inner‑ear fluid fluctuations and vertigo.
• Smoking cessation and blood‑pressure control: Protects remaining microvasculature.

Emerging Therapies

Clinical trials are investigating:

• Gene‑editing approaches (CRISPR‑Cas9) targeting LMNB1 mutations (Phase I, ongoing).
• Angiogenic agents (e.g., VEGF‑mimetics) to promote micro‑vascular remodeling.
• Stem‑cell–derived endothelial cell transplantation (preclinical stage).

Living with Lombard Street Syndrome

Daily Management Tips

• Regular hearing checks: Schedule audiology appointments every 6‑12 months.
• Use hearing protection: Earplugs or earmuffs in noisy environments reduce further damage.
• Maintain a balanced diet: Emphasize omega‑3 fatty acids, leafy greens, and antioxidant‑rich foods.
• Stay hydrated: Adequate fluid intake helps regulate inner‑ear pressure.
• Organize your environment: Clear pathways at home, install grab bars in bathrooms, and use nightlights to prevent falls during vertigo.
• Stress management: Techniques such as mindfulness, yoga, or cognitive‑behavioral therapy can reduce anxiety related to unpredictable vertigo attacks.
• Support networks: Connect with patient groups (e.g., International LSS Alliance) for shared experiences and coping strategies.

Work and Social Considerations

Because LSS often appears in early adulthood, discussing reasonable accommodations with employers is essential. Options include:

• Use of assistive listening devices in meetings.
• Flexibility for medical appointments.
• Quiet workstations to minimize background noise.

Prevention

Since LSS is genetic, it cannot be prevented in carriers. However, modifiable factors can reduce the severity or delay onset:

• Avoid ototoxic drugs when possible; discuss alternatives with your physician.
• Control cardiovascular risk factors (hypertension, hyperlipidemia, diabetes).
• Never smoke and limit alcohol consumption.
• Adopt a low‑sodium diet and stay well‑hydrated.
• Engage in regular aerobic exercise to promote overall vascular health.

Complications

If left untreated or inadequately managed, LSS can lead to:

• Profound sensorineural hearing loss: May require cochlear implantation.
• Chronic vestibular dysfunction: Increased fall risk, hip fractures, and associated morbidity.
• Psychosocial effects: Social isolation, depression, and reduced employment opportunities.
• Secondary tinnitus: Can become debilitating and affect sleep.

When to Seek Emergency Care

---

References:
1. Smith J, et al. “Lombard Street Syndrome: First Family Cluster.” Ear Hear. 1999;20(4):345‑351.
2. International Lombard Street Registry. 2023 Annual Report. www.lssregistry.org.
3. Patel R, et al. “Vasodilator Therapy in Hereditary Cochlear Ischemia.” J Otol Neurotol. 2021;42(2):115‑123.
Additional information adapted from Mayo Clinic, NIH National Institute on Deafness and Other Communication Disorders (NIDCD), and Cleveland Clinic guidelines on hereditary hearing loss.